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1. Overview of peritonitis 
“Peritonitis is 
still the Achilles 
heel of 
peritoneal 
dialysis”
(Mactier 2009)
Extent of peritonitis
➢Peritonitis is the most common peritoneal dialysis (PD) complication 
and the principal cause of PD-failure (Mactier 2009)
➢Peritonitis is the cause of death for 4% of patients using PD and a 
contributing factor for 16% (Li et al. 2016)
➢No international reporting of peritonitis rates.
Diagnosis
• Two of the following:
1. Clinical features of peritonitis, e.g. abdominal pain and/or cloudy dialysis 
effluent
2. Dialysis effluent white cell count >100/μL or >0.1 × 109/L (after a dwell time 
of at least 2 hours), with > 50% polymorphonuclear
3. Positive dialysis effluent culture (Li et al. 2016)
• Peritonitis is caused by: skin or environmental contamination, 
catheter-related, bacteraemia, bowel and gynaecological flora 
(Piraino et al. 2016)
Treatment
• Antibiotic treatment administered orally, 
intravenously or via intraperitoneal, prescription 
dependent on causative organism (Li et al. 2010)
✓International Society for Peritoneal Dialysis guidelines (Li 
et al. 2016)
• May require hospital admission, some patients may 
self-manage at home with support from PD 
healthcare professionals.  
Consequences
➢Serious consequences: peritoneal membrane failure = withdrawal 
from PD (Li et al.2016)
➢Other complications (Levy et al. 2016): 
• Malnutrition
• Loss of ultrafiltration
• Fungal peritonitis
• Intraabdominal sepsis
• Adhesions
• Ileus (rarely)
2. Psychosocial impact of 
peritonitis 
Study overview
Author Year Country Study design Number of participants
Juergenson et al. 1996 USA Quantitative cross-sectional, single-
centre
68
Juergenson et al. 1997 USA Quantitative cross-sectional, single-
centre
103
Bakewell et al. 2002 UK Quantitative longitudinal, single-
centre
88
Troidle et al. 2003 USA Quantitative longitudinal, single-
centre
162
Peritonitis is associated with:
• Worse quality of life (Juergenson et al. 1996, Juergenson et al. 1997, 
Bakewell et al. 2002)
• Anxiety (Juergenson et al. 1996, Juergenson et al. 1997)
• Depression (Juergenson et al. 1997, Troidle et al. 2003)
• Hospitalisation (Bakewell et al. 2002)
• Transfer to haemodialyis (Bakewell et al. 2002)
3. Patients’ and families’ 
experiences of peritonitis 
A lack of evidence 
A systematic review and thematic synthesis of 
qualitative studies considering peritoneal dialysis 
recommended:
“research on patient perspectives specifically about 
peritonitis be conducted because this issue was 
virtually absent across studies.” 
(Tong et al. 2013: 886)
Baillie and Lankshear (2015)
• UK ethnographic study 
• Data collected 2011
• Patients (n=16) and relatives (n=9) from 
one National Health Service (NHS) 
organisation
• Participants interviewed and observed 
using peritoneal dialysis in their homes
• Data analysed thematically 
Key findings
• Peritonitis was frequently discussed by participants, who were aware 
of the serious consequences
• Prevention of peritonitis was an important aspect of PD training
• Participants worked daily to prevent peritonitis, which they were 
fearful of
• Some participants were confused about monitoring of peritonitis
• Healthcare professionals offered additional support if peritonitis was 
diagnosed, while participants felt guilty
Training
“when the nurse came and she was 
training us up on the whole system how to 
use it, that was really daunting and scary… 
that was very very difficult I think the first 
couple of months to get a routine and to 
get used to it… you’ve got to make sure 
your hands are clean and you’re washing 
them and then you’ve got to get all the 
instruments all out and make sure that all 
like sanitation… and the whole thing, at 
the time, we just thought “we can’t do it, it 
just seems too much” (Lisha, daughter of 
Leila, 60s, CAPD, p.181)
“she [PD nurse] was 
impressing on me the 
care to avoid infection of 
course, that was the big 
thing with her” (Norman, 
80s, APD, p.180)
Prevention
“Kaye: look at my [indicates short 
nails] I don’t use a lot of soap now I 
use… hibiscrub and in the 
[bedroom] I always keep a bottle of 
the 
Kris: alcohol
Kaye: rub because I use that all the 
time when I’m dealing with the 
machine, before I touch you in the 
morning as well I always wipe my 
hands” (Kris and wife Kaye, 80s, 
APD, p.181) 
‘Daniel and Diane talked about going 
out and said that CAPD never 
stopped them. Diane explained that 
they used to take out a container of 
water with them for Daniel to wash 
his hands, but eventually they 
stopped doing that but ensured that 
he had extra alcohol hand-gel and 
used a clean paper towel to open 
packaging for performing the dialysis 
exchange” (Fieldnotes Daniel and 
wife Diane, 70s, APD, p.182) 
Monitoring
“Researcher: what else are you 
looking for?
Carl: cloudy and that’s clear, so 
I’ve got no infections” (Carl, 
60s, both CAPD and APD, 
p.181)
“Janice: they always told us if he had it we would know 
he had it, cos you did ask what were the signs didn’t 
you and they said if he got it you’ll know.  Well we 
didn’t cos his bags
Julie: he didn’t have no fibrin, no tell-tale signs, again
Janice: the only thing was that it was a little bit darker
Julie: a little bit cloudy
Janice: bit cloudy, but that was all
Julie: nothing glaring…
Janice: I mean but you’d have one bag that would be 
cloudy but then the next one would be fine
Julie: because you’d say to yourself ‘right if the next one 
is like it I’ll phone the hospital’ and then that would be 
lovely… it wasn’t consistent” (Janice and Julie, wife and 
daughter of James, 70s, both CAPD and APD, p.181)
Identification and intervention
“We’ve never felt we’ve had anything other 
than 100% support and like I say if they feel 
it’s necessary they’ll be out.  He’s had 
peritonitis twice I think, maybe three times, 
but they’re on the case immediately.  So 
obviously they’re relying on us to flag them 
up if there’s a problem, there’s not a lot 
they can do if we don’t say ‘look I don’t 
think this is right’” (Christine, wife of Carl, 
60s, both CAPD and APD, p.183)
“Janice: she [nurse] said ‘well if we’d caught 
it earlier it wouldn’t have been so bad’ but 
we didn’t know…
Julie: and it was like that ‘if we’d caught it 
earlier we could’ve’ well you’re thinking ‘is 
it our fault, you know? Why didn’t we know, 
you know?  What were we missing?’” 
(Janice and Julie, wife and daughter of 
James, 70s, both CAPD and APD, p.183)
Implications for practice
• Patients and families need ongoing education and training to prevent, 
monitor and manage peritonitis;
• Patients and families need constructive support from healthcare 
professionals when peritonitis is suspected and diagnosed;
• Further research is needed to examine patients’ and families’ 
understanding of peritonitis.
Campbell et al. (2016)
• Australian grounded theory study
• Data collected 2014-2015
• Patients (n=29) recruited from three 
hospitals
• Participants interviewed in person or 
via Skype
• Data analysed thematically 
Key findings
• Peritonitis was perceived as an ongoing threat and participants 
recognised it could lead to withdrawal from PD and death;
• Participants felt family members should be trained to understand the 
risk;
• Participants tried to minimise the risk of developing peritonitis, but 
struggled to recognise the signs and symptoms of an episode;
• Peritonitis was more painful than participants anticipated and made 
them very unwell, which they felt affected their dignity;
• Peritonitis led to participants missing work, being separated from 
their families and relying further on family members.
Constant vigilance for prevention
“Scared me in a sense that, at the back of 
my mind I was thinking I’m going to get it 
again. So that’s what I said, when I do my 
bags, I’m so careful now just to make sure 
nothing goes wrong.” (Male, 40s, CAPD, 
p.633)
“You were always worried 
you might get peritonitis 
because you talk to people 
who get 3 or 4 or 5 episodes 
a year and they appear to 
do everything right. I did 
everything as close as I 
could to right. That’s always 
in the back of your mind.” 
(Male, 60s, HD and CAPD, 
p.633)
Invading harm
“I was worried because they 
had said that people have died 
from peritonitis. So yeah, I was 
quite scared. I was thinking, 
well first of all I was in so much 
pain I just wanted it to go 
away, then when they 
confirmed I had peritonitis I 
was thinking, I hope I don’t 
die. I hope it’s not that bad.” 
(Male, 30s, HD and APD, 
p.634)
“I just remember pain. Being 
asleep and being in pain. 
Painkillers, sleeping tablets, 
pain. It was shocking. It was 
the worst feeling.” (Male, 40s, 
HD, CAPD and APD, p.634)
Incapacitating lifestyle interference
“Didn’t go to work for 5 
weeks and what it costs you 
through loss of income. I had 
to shut down my catering 
business. I lost half a million 
dollars.” (Male, 40s, HD, CAPD 
and APD, p.634)
“Family life, yeah obviously there was a 
little bit of disruption because obviously I 
had to—again my mum was a saint at the 
time when she was able to help me. She 
would help me every morning and she’d 
make sure I was okay before I went to 
work. Or make sure I was okay after I went 
and saw the doctors.” (Male, 30s, HD and 
APD, p.635)
Exasperation with hospitalization
“I’d have to break my normal routine 
of a morning where I’d have to get up 
a little bit earlier. I’d have to run 
around and do all the antibiotics into 
the bag and do the fresh bag. That 
took a little bit longer than normal but 
it wasn’t too bad it was just the odd—
every 2 or 3 days I’d be at the hospital 
for check-ups and blood tests.” (Male, 
30s, HD and APD, p.635)
“It’s just you go in and you know 
you’re going to end up in emergency. 
You know you are going to have a 
night with no sleep in there. Then 
you’ll be spending a few days while 
they do all the stuff they have to do, 
to make sure that everything is alright. 
No one likes being in hospital and I 
don’t like it either.” (Male, 50s, APD 
and CAPD, p.635)
Implications for practice
• Information, education and training, e.g. frequent retraining
• Psychological support, e.g. referral to psychological services
• Clinical support, e.g. on call nephrologist/PD nurse
• Social support, e.g. childcare at hospital
4. Patients’ and families’ 
knowledge of peritonitis
Study overview
Author Year Country Study design Number of 
participants
Russo et al. 2006 Italy Quantitative cross-sectional, multicentre 
(n=11), phase one (questionnaire), phase 
two (patient behaviour assessment)
Phase 1: 353
Phase 2: 191
Kazancioglu
et al. 
2008a Turkey Quantitative cross-sectional, single-centre, 
questionnaire
32
Kazancioglu
et al.  
2008b Turkey Quantitative cross-sectional, single-centre, 
questionnaire
32
Ozturk et al. 2009 Turkey Quantitative longitudinal, single-centre, 
questionnaire
15
Sayed et al. 2013 Sudan Quantitative cross-sectional, single-centre, 
questionnaire and observation 
50
Knowledge of peritonitis
➢Patients lacked knowledge around the following aspects of peritonitis 
(Kazancioglu et al. 2008a, Kazancioglu 2008b, Ozturk et al. 2009, 
Russo et al. 2006, Sayed et al. 2013):
• What it is;
• Signs/symptoms;
• Prevention, including hand washing, exit-site care, managing dialysis space, contamination 
procedure.
• Patients with higher knowledge scores had lower rates of peritonitis (Kazancioglu
2008a, Sayed et al. 2013);
• Patients who complied to PD exchange procedures were less likely to develop 
peritonitis (Russo et al. 2006).
5. Future directions

What we know:
• Peritonitis is painful and 
debilitating, and is feared by 
patients;
• Patients work hard to prevent 
peritonitis;
• Patients are not always familiar 
with the signs and symptoms of 
infection.
• What patients and their families 
know about peritonitis;
• How patients and their carers 
make decisions about accessing 
support for peritonitis; 
• How can we meet patients’ and 
families’ information and 
support needs.
What we don’t know:
Knowledge, understanding and 
experiences of peritonitis 
amongst patients, and their 
families, undertaking peritoneal 
dialysis: A mixed methods study
Study aim and objectives 
• The aim of this mixed methods study is to examine patients’ and 
families’ knowledge and experiences of PD-associated peritonitis. 
• Study objectives are to: 
1. Design, pilot and utilise a structured questionnaire to identify 
patients’ and families’ knowledge and experience of peritonitis; 
2. Explore in depth patients’ and families’ knowledge and experiences 
of peritonitis via semi-structured interviews; 
3. Synthesise the quantitative and qualitative data. 
Study Design 
Mixed methods
Phase One:
Questionnaire
Phase Two:
Interviews
Phase one: Questionnaire
• Surveys patients’ and families’ knowledge and experience of PD-associated 
peritonitis: Knowledge, experience, demographics;
• Sent to all eligible patients in six sites in England and Wales;
➢Using PD;
➢Used PD within one year, but currently using haemodialysis 
or with a kidney transplant;
➢Patients asked to include relatives.
• Questionnaire developed from literature/guidelines, with input from key 
stakeholders
Questions
Part One: Knowledge of peritonitis
• What is peritonitis?
• What can cause peritonitis?
• Which of the following actions can help to reduce the risk 
of developing peritonitis?
• Which of the following options are signs and symptoms 
of peritonitis?  
• What would you do if contamination occurred to your 
line during connection/ disconnection?
• If you use APD, how often should you check the fluid you 
drain out?
• What would you do if you thought you might have 
peritonitis?
• What do you think the clinical team would do if they 
suspect you have peritonitis?
• What are the possible serious consequences of 
peritonitis?
Part Two: Experience of peritonitis
• Have you ever had peritonitis since using 
peritoneal dialysis?
• What made you suspect you might have 
peritonitis?
• What happened after you suspected you 
might have peritonitis?
• What happened when you were told you had 
peritonitis?
• Do you know what caused your peritonitis?
• Did you receive any further training from the 
clinical team (nurses/doctors) to use 
peritoneal dialysis after you developed 
peritonitis?
• How worried are you about developing 
peritonitis now?
• Where do look for information about 
peritonitis?
Phase two: Interviews
• Sample of willing Phase One participants (n=30) invited to participate:
• Patients and relatives;
• From each site;
• Variety in the sample: gender, age, location, 
type of dialysis (CAPD/APD), length of time 
using PD and whether they have or have not 
experienced peritonitis. 
• Semi-structured interviews to explore in-depth patients’ and families’ 
experiences of peritonitis, via Skype, telephone or in-person.

Conclusions
Conclusions
• Peritonitis is a debilitating complication that impacts negatively on 
patients and their families;
• A proportion of patients and their families are unfamiliar with the 
signs and symptoms of peritonitis;
• Patients and families need educational and emotional support, but 
what should this involve?
Thank you very much
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Mange tak
Dr Jessica Baillie
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